FDA Inspection
Apotex Inc.Apotex Inc. – FDA Inspection, Sep 14, 2022
Record Details
This FDA Inspection record concerns Apotex Inc., with an inspection on September 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Apotex Inc.
- Inspection Date
- September 14, 2022
- Product Type
- Drugs
View Company Profile
ID · 99deead7-3985-44ad-8d26-0bbc68e18b92
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1179507
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Apotex Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| March 8, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 28, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Apotex Inc.
- FDA Inspection 1269710 - 2025-05-09
- FDA Inspection 1231036 - 2024-03-08
- FDA Inspection 1203170 - 2023-03-24
- FDA Inspection 1098988 - 2019-06-28
- FDA Inspection 1086265 - 2019-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.